Standout Papers
Citation Impact
Citing Papers
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
2015 Nobel
Serum NFL discriminates Parkinson disease from atypical parkinsonisms
2019
Low clinical diagnostic accuracy of early vs advanced Parkinson disease
2014
The potential prognostic role of cardiovascular autonomic failure in α‐synucleinopathies
2012
MDS research criteria for prodromal Parkinson's disease
2015
New clinical trials for nonmotor manifestations of Parkinson's disease
2015
Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy
2017
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
2015
Psychiatric Complications in Parkinson Disease
2005
The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy
2011
Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study
2015
[123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
2007
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Long-term effects of exercise and physical therapy in people with Parkinson disease
2017
Diminished iron concentrations increase adenosine A2A receptor levels in mouse striatum and cultured human neuroblastoma cells
2008
New developments of brain imaging for Parkinson's disease and related disorders
2006
Olfaction in Parkinson's disease and related disorders
2011
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
2010
Restless Legs Syndrome
2008
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy
2008
Vascular dementia
2015 Standout
Riluzole in the Treatment of Mood and Anxiety Disorders
2008
123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis
2012
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
2013
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Connectivity-based segmentation of the striatum in Huntington's disease: Vulnerability of motor pathways
2011
Subclinical Atherosclerotic Changes Related to Chronic Kidney Disease in Asymptomatic Black and White Young Adults: The Bogalusa Heart Study
2011
The clinical use of structural MRI in Alzheimer disease
2010
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Neurochemistry and the non-motor aspects of PD
2011
Dopamine agonists in the treatment of early Parkinson's disease: A meta-analysis
2008
Parkinson's disease: clinical features and diagnosis
2008 Standout
Premotor Parkinson's disease: Concepts and definitions
2012
Association of Olfactory Bulb Volume and Olfactory Sulcus Depth with Olfactory Function in Patients with Parkinson Disease
2011
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Spreading of pathology in neurodegenerative diseases: a focus on human studies
2015
Voxel-based morphometry in autopsy proven PSP and CBD
2006
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
2009 Standout
Cognitive status correlates with neuropathologic stage in Parkinson disease
2005
Is COVID-19 a Perfect Storm for Parkinson’s Disease?
2020
Brainstem pathology and non-motor symptoms in PD
2009
The cause of death in idiopathic Parkinson’s disease
2010
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
2003
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
2013
White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study
2009
Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data
2017
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
2015
Parkinson's disease
2009 Standout
Priorities in Parkinson's disease research
2011
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction
2009
Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease
2005
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Foraging under Competition: The Neural Basis of Input-Matching in Humans
2013 StandoutNobel
Neurochemical biomarkers in the differential diagnosis of movement disorders
2009
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
2015
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor
2010 Standout
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
2012
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy
2013
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Parkinson's disease in the Western Pacific Region
2019
Structural Imaging in Parkinson’s Disease: New Developments
2019
Parkinson's disease
2015 Standout
Ferritin for the clinician
2008
The Role of the Dorsal Striatum in Reward and Decision-Making: Figure 1.
2007
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
2013
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
2014
Ten steps to identify atypical parkinsonism
2006
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
2003
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy
2007
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France
2007
Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia
2006
Differentiating Parkinson’s disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test
2011
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study
2007
The progression of pathology in longitudinally followed patients with Parkinson’s disease
2008
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Altered Proteins in the Aging Brain
2016
Estimated life expectancy of Parkinson's patients compared with the UK population
2007
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series
2013
Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment
2018
Neuropathologic substrates of Parkinson disease dementia
2012
Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures
2004
Non-motor features of Parkinson disease
2017 Standout
Association of Albuminuria and Cancer Incidence
2008
Gastrointestinal dysfunction in Parkinson's disease
2015
Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
2003
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies
2018
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
2011
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
2020
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
NOvelty-related Motivation of Anticipation and exploration by Dopamine (NOMAD): Implications for healthy aging
2009
Glia and alpha-synuclein in neurodegeneration: A complex interaction
2015
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Imaging biomarkers in Parkinson's disease
2011
Alzheimer's Disease
2004 Standout
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Non motor subtypes and Parkinson's disease
2015
The diagnosis of Parkinson's disease
2005
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
Hyposmia and cognitive impairment in Gaucher disease patients and carriers
2012
Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
2005
Magnetic resonance imaging of the substantia nigra in Parkinson's disease
2012
Challenges of multimorbidity of the aging brain: a critical update
2014
Chronic Kidney Disease
2016 Standout
Drooling in Parkinson's disease: A review
2014
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Death certificate data and causes of death in patients with parkinsonism
2017
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders
2014
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
2008 StandoutNobel
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013
Biological fluid biomarkers in neurodegenerative parkinsonism
2009
How to diagnose multiple system atrophy
2005
Parkinson's Disease
2003 Standout
Metabolic issues and cardiovascular disease in patients with psychiatric disorders
2005
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
2018
The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
2019
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
Mortality in Parkinson's disease: A systematic review and meta‐analysis
2014
Vascular P arkinsonism: D econstructing a S yndrome
2015
Nonmotor symptoms of Parkinson’s disease
2006
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Huntington?s disease: pathomechanism and therapeutic perspectives
2004
EPIDEMIOLOGY OF NEURODEGENERATION
2003
Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine
2019
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
2018
Therapeutic prospects for Parkinson disease
2013
Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis
2006
Accuracy of clinical diagnosis of Parkinson disease
2016
Alimentary, my dear Watson? The challenges of enteric α‐synuclein as a Parkinson's disease biomarker
2013
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological Treatment of Parkinson Disease
2014
The neurobiological basis of cognitive impairment in Parkinson's disease
2014
Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders
2014
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
1992 Standout
Combination therapies: The next logical Step for the treatment of synucleinopathies?
2015
Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease
2012
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Progression marker of Parkinson’s disease: a 4-year multi-site imaging study
2017
Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations
2019
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes
2018
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
2019
Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease [RETIRED]
2010
Neuropathology of prodromal Lewy body disease
2014
Non-motor Symptoms of Parkinson's Disease
2007
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
Importance of low diagnostic Accuracy for early Parkinson's disease
2018
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
2018
Blood NfL
2019
Dementia with Lewy bodies.
2004
Regional patterns of brain tissue loss associated with depression in Parkinson disease
2010
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
The association of incident dementia with mortality in PD
2002
Psychiatric Complications in Parkinson Disease
2005
Parkinson risk in idiopathic REM sleep behavior disorder
2015
Hallucinations in Parkinson's disease--a study of forty three patients.
2004
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
The organization of the human cerebellum estimated by intrinsic functional connectivity
2011 Standout
Cardiovascular Autonomic Dysfunction in Animal Models of Parkinson's Disease
2011
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease
2016
Neuronal vulnerability, pathogenesis, and Parkinson's disease
2012
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
2017
Diffusion tensor imaging in parkinsonian syndromes
2013
Interventions for fatigue in Parkinson's disease
2015
Update of the MDS research criteria for prodromal Parkinson's disease
2019
Works of Klaus Seppi being referenced
Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.
2004
Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population‐based 10‐year study
2018
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
2019
Towards translational therapies for multiple system atrophy
2014
Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly
2010
Parkinson disease
2017 Standout
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
2019
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease
2010
Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy
2007
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease
2013
Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study
2006
Brain Magnetic Resonance Imaging Techniques in the Diagnosis of Parkinsonian Syndromes
2009
Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment
2000
Orthostatic hypotension and attention in Parkinson’s disease with and without dementia
2006
Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study
2005
Increased daytime sleepiness in Parkinson's disease: A questionnaire survey
2002
Freezing of gait in postmortem‐confirmed atypical parkinsonism
2002
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
2010
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
2004
Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
2017
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome
2005
Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease
2005
Topography of Dopamine Transporter Availability in Progressive Supranuclear Palsy
2006
Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease
2004
Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
2004
Treatment options for depression and psychosis in Parkinson's disease
2001
Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
2005
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
2014
The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism
2018
Mortality in Parkinson's disease: A 20‐year follow‐up study
2009
Restless legs syndrome in Parkinson's disease
2009
Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy
2003
Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder
2009
Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease
2001
Voxel-wise analysis of [123I]β-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease
2005
Polycystic ovaries, obesity and insulin resistance in women with epilepsy
2002
Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial
2019
Drug safety evaluation of rotigotine
2012
Midbrain sonography in patients with essential tremor
2007
Placebo‐controlled trial of riluzole in multiple system atrophy
2006
Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study
2006
Cerebrospinal fluid hypocretin‐1 levels in multiple system atrophy
2007
White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: A diffusion‐tensor imaging and voxel‐based morphometry study
2010
Multiple System Atrophy
2001
Risk factors and prodromal markers and the development of Parkinson’s disease
2013
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
2002
Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort
2004
Riluzole in Huntington's disease (HD): an open label study with one year follow up
2001
Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?
2012
Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population
2004
An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism
2005
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Predictors of Survival in Dementia with Lewy Bodies and Parkinson Dementia
2007
Diffusion‐weighted imaging in Huntington's disease
2006
Validation of the MDS Clinical Diagnostic Criteria for Parkinson’s Disease (S3.001)
2018
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
2015
Modafinil for the Treatment of Daytime Sleepiness in Parkinson´s Disease: A Double-blind, Randomized, Crossover, Placebo-controlled Polygraphic Trial
2002
Nonmotor S ymptoms in S ubjects W ithout E vidence of D opaminergic D eficits
2015
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community
2016
The PRIPS study: screening battery for subjects at risk for P arkinson's disease
2012
Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder
2017
Restless legs syndrome
2005
The role of high‐field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward
2017
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
2018
Mortality in Parkinson's disease: A 38‐year follow‐up study
2014
Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease
2017
Which dyskinesia scale best detects treatment response?
2013
Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group
2014
Transient restless legs syndrome after spinal anesthesia
2002
Intoxication with riluzole in Huntington’s disease
2001
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Five‐year follow‐up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder
2014
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy
2003
Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD
2002